| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 20.906 | 20.757 | 19.118 | 54.970 | 60.016 |
| Total Income - EUR | - | - | - | - | 4.655 | 44.780 | 31.395 | 28.247 | 67.148 | 66.892 |
| Total Expenses - EUR | - | - | - | - | 11.118 | 34.580 | 35.081 | 36.668 | 50.382 | 40.854 |
| Gross Profit/Loss - EUR | - | - | - | - | -6.463 | 10.200 | -3.686 | -8.422 | 16.765 | 26.038 |
| Net Profit/Loss - EUR | - | - | - | - | -6.463 | 10.005 | -3.894 | -8.613 | 16.226 | 25.319 |
| Employees | - | - | - | - | 3 | 4 | 4 | 4 | 4 | 2 |
Check the financial reports for the company - Lorasept Anc S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 37.820 | 30.098 | 24.133 | 16.566 | 9.449 | 18.217 |
| Current Assets | - | - | - | - | 2.156 | 8.479 | 6.635 | 5.565 | 8.698 | 18.128 |
| Inventories | - | - | - | - | 0 | 830 | 833 | 1.799 | 1.243 | 418 |
| Receivables | - | - | - | - | 0 | 99 | 332 | 132 | 1.819 | 3.466 |
| Cash | - | - | - | - | 2.156 | 7.550 | 5.471 | 3.635 | 5.636 | 14.244 |
| Shareholders Funds | - | - | - | - | -6.421 | 3.706 | -270 | -8.884 | 7.369 | 32.647 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 10.014 | 6.335 | 10.133 | 17.063 | 3.866 | 3.698 |
| Income in Advance | - | - | - | - | 36.383 | 28.537 | 20.906 | 13.952 | 6.911 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8123 - 8123" | |||||||||
| CAEN Financial Year |
8129
|
|||||||||
Comments - Lorasept Anc S.r.l.